U.S., Feb. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07402486) titled 'A Phase II Prospective Study of Maastro Applicator Brachytherapy for Rectal Cancer' on Feb. 04.
Brief Summary: Rectal cancer is a common type of cancer and an important cause of illness and death worldwide. In 2020, cancers of the colon and rectum were the fourth most common cancers globally, and about one third of these cases were rectal cancer. Surgery is the main treatment for rectal cancer. In more advanced cases, chemotherapy and external beam radiotherapy are often given before surgery. However, surgery can sometimes result in a permanent stoma (an opening on the abdomen for bowel movements) and carries higher risks of complic...